Immucell Corp Stock
Your prediction
Immucell Corp Stock
There is an upward development for Immucell Corp compared to yesterday, with an increase of €0.15 (1.550%).
Pros and Cons of Immucell Corp in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immucell Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immucell Corp | 1.550% | 1.031% | 13.295% | 76.577% | 92.157% | 106.751% | 15.294% |
| Larimar Therapeutics Inc. | 5.060% | -5.682% | 25.758% | 24.812% | 0.000% | 19.424% | -61.618% |
| Northwest Biotherapeutics Inc. | -1.330% | 0.000% | 2.069% | -35.088% | -28.155% | -68.511% | -86.038% |
| Achieve Life Sciences Inc. | 1.890% | 0.935% | 0.000% | 135.808% | 45.946% | 5.882% | -10.744% |
News
ImmuCell Q1 Earnings Call Highlights
ImmuCell (NASDAQ:ICCC) reported a record first quarter of 2026, with management saying the company’s narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever
